Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15754346 | 0.88 | LMNA (0.39) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL3851271 | 0.88 | LMNA (0.39) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL599665 | 0.88 | LMNA (0.39) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL8718435 | 0.88 | LMNA (0.39) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL7851711 | 0.78 | AKR1B1 (0.32) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL2773788 | 0.78 | AKR1B1 (0.32) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL1389456 | 0.78 | AKR1B1 (0.32) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL2772124 | 0.78 | AKR1B1 (0.32) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL6429913 | 0.78 | PTPN1 (0.38) | — | |
| SCHEMBL139867 | 0.78 | PTPN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106907-A1 | FAST PCR BY TANDEM PRIMER EMBEDDED WITH RIBONUCLEOTIDE | CEPHEID (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20250197850-A1 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH REDUCED AMPLIFICATION TIME | CEPHEID (US) | 2025-06-19 | — | — | US | disclosed |
| CN-113227398-B | Exponential radix-3 nucleic acid amplification with nested overlapping primers at reduced amplification time | 塞弗德公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240401157-A1 | RESPIRATORY BIOMARKER PANEL | CEPHEID (US) | 2024-12-05 | — | — | US | disclosed |
| US-12098368-B2 | Exponential base-3 and greater nucleic acid amplification with reduced amplification time | CEPHEID (US) | 2024-09-24 | — | — | US | disclosed |
| US-20230167490-A1 | PSEUDO-COMPLEMENTARY BASES IN GENOTYPING AND NUCLEIC ACID SEQUENCING | CEPHEID (US) | 2023-06-01 | — | — | US | disclosed |
| CN-116113709-A | Pseudo complementary bases in genotyping and nucleic acid sequencing | 塞弗德公司 | 2023-05-12 | — | — | CN | disclosed |
| US-20230096557-A1 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH REDUCED AMPLIFICATION TIME | CEPHEID (US) | 2023-03-30 | — | — | US | disclosed |
| EP-4143336-A1 | PSEUDO-COMPLEMENTARY BASES IN GENOTYPING AND NUCLEIC ACID SEQUENCING | Cepheid (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-4143335-A1 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | Cepheid (US) | 2023-03-08 | — | — | EP | disclosed |
| CN-115702250-A | Nucleic acid amplification with index base-3 and above using cycling probe | 塞弗德公司 | 2023-02-14 | — | — | CN | disclosed |
| US-11352622-B2 | Exponential base-3 and greater nucleic acid amplification with reduced amplification time | CEPHEID (US) | 2022-06-07 | — | — | US | disclosed |
| US-20210403981-A1 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | CEPHEID | 2021-12-30 | — | — | US | disclosed |
| WO-2021222144-A1 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | CEPHEID (US) | 2021-11-04 | — | — | WO | disclosed |
| WO-2021222289-A1 | PSEUDO-COMPLEMENTARY BASES IN GENOTYPING AND NUCLEIC ACID SEQUENCING | CEPHEID (US) | 2021-11-04 | — | — | WO | disclosed |
| EP-3874064-A1 | EXPONENTIAL BASE-3 NUCLEIC ACID AMPLIFICATION WITH REDUCED AMPLIFICATION TIME USING NESTED OVERLAPPING PRIMERS | Cepheid (US) | 2021-09-08 | — | — | EP | disclosed |
| CN-113227398-A | Exponential-base-3 nucleic acid amplification with nested overlapping primers at reduced amplification time | 塞弗德公司 | 2021-08-06 | — | — | CN | disclosed |
| US-20200239878-A1 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH REDUCED AMPLIFICATION TIME | CEPHEID (US) | 2020-07-30 | — | — | US | disclosed |
| US-5912340-A | FORMING STABLE HYBRID WITH DNA, RNA | EPOCH PHARMACEUTICALS, INC. (US) | 1999-06-15 | — | — | US | disclosed |
| WO-1997012896-A1 | SELECTIVE BINDING COMPLEMENTARY OLIGONUCLEOTIDES | EPOCH PHARMACEUTICALS, INC. (US) | 1997-04-10 | — | — | WO | disclosed |